Sherbrooke - Médecine nucléaire
Université de SherbrookeSherbrooke, QuebecRegular stream
From the 2026 match (R-1 2026). See the 2027 version
- 2 positions
- 5 years
- Regular
- Médecine nucléaire
- 0–50
- 76–100%
- Not stated on CaRMS page
- 29244
Summary
The Nuclear Medicine residency program at Université de Sherbrooke combines clinical and fundamental learning through weekly courses over two years, with varied clinical exposure using advanced technological equipment. Learning occurs in a friendly environment under direct supervision of engaged teachers who prioritize resident success.
Training
- Research
- Residents are encouraged to engage in retrospective or prospective research projects, with a dedicated research budget to support their work.
- Training setting
- Training occurs primarily at CIUSSS de l'Estrie: Fleurimont Hospital and Hôtel-Dieu, with additional rotations in Montreal, Quebec City, and other affiliated centers.
- Teaching approach
- Competence-based medical education with progressive independence, emphasizing direct supervision, structured learning, and gradual clinical responsibility.
- Setting types
- Academic medical center
- University hospital
- Research center
- Focus areas
- Nuclear Medicine
- Medical Imaging
- Radiopharmaceutical Therapy
- Clinical Research
- Patient populations
- Oncology patients
- Pediatric patients
- Cardiology patients
- Endocrinology patients
- Surgical patients
- Highlights
- Competence by Design (CBD) curriculum
- Weekly structured courses
- Research involvement encouraged
- Clinical Research Center access
- Advanced technological equipment (SPECT-CT cameras, PET-CT cameras, medical cyclotrons)
- Strengths
- Comprehensive 5-year training program
- Dynamic and engaged teaching team
- Varied clinical exposure
- Strong research opportunities
- Advanced technological infrastructure
- Enhanced skills
- Radiopharmaceutical therapy
- PET-CT techniques
- Pediatric nuclear medicine
By year
- PGY-1
- Hémato-oncologie2 périodes
- Radio-oncologie2 périodes
- Cardiologie1 période
- Cardiologie de laboratoire1 période
- Endocrinologie1 période
- Médecine interne1 période
- Pneumologie1 période
- Introduction à la recherche/RSS-7031 période
- Néphropédiatrie/Endocrinopédiatrie/hématooncopédiatrie1 période
- Spécialité chirurgicale: Orthopédievs Urologie1 période
- Introduction en médecine nucléaire(P2 ou P3)1 période
- PGY-2
- Médecine nucléaire (senior)Au moins 10 périodes
- TEP-TDMAu moins 5 périodes
- Stages optionnels4 périodes
- Pédiatrie nucléaire2 périodes obligatoires
- Radiologie (ORL)1 période
Selection
- What the program looks at
- Academic performance
- Clinical evaluation
- Research involvement
- Interpersonal skills
- Professional attitude
- Motivation for Nuclear Medicine
- Applications per year
- 0–50
- Applicants offered interviews
- 76–100%
Interviews
- Dates (2026 match)
- 29 janvier 2026; 30 janvier 2026
Pay
| Level | Annual salary |
|---|---|
| PGY-1 | $58,728 / year |
| PGY-2 | $64,809 / year |
| PGY-3 | $70,890 / year |
| PGY-4 | $76,969 / year |
| PGY-5 | $83,050 / year |
Benefits
- Adoption leave
- 29 to 38 weeks55 to 75 % of salary
- Annual vacation
- 20 days/year
- Assistant Resident Coordinator
- $425/month
- Call Premium
- $607/28 days
- Conference leave
- 7 days pd/year
- Dental Plan
- Yes, available for a fee
- Exam leave
- Day (s) of the exam
- Extended Health Insurance
- Yes
- Leave for death in family
- From 1 to 5 days depending on the family member
- Leave of absence without pay (exceptional measure)
- 12 months maximum
- Life insurance
- Yes
- Long-Term disability insurance
- Yes
- Maternity leaveProvincial Program (RQAP*) and FMRQ **
- 21 weeks95 % of salary
- Meals
- Reduced feeFree during on-call duty
- Pager
- Provided by the establishment
- Parental leave (time sharing between parents)
- 19 to 29 weeks55 to 75 % of salary
- Parking
- ½ of doctors’ feeFree during on-call duty
- Paternity leaveProvincial Program (RQAP) and FMRQ
- 1 week, 100% of salary3 to 5 weeks, 100% of salary(two options)
- Professional Liability Insurance****(CPMA not applicable)
- Yes (free)
- Quebec Health Insurance Program / RAMQ***
- Yes
- Resident Coordinator
- $583/month
- Resuscitation courses and examination leave
- Day of the course and of the exam, course paid
- Sick leave
- 9.6 days pd / yearAnd reimbursement of days not taken
- Statutory and floating holidays
- 13/year
- Study leave
- 10 days pd/year
- Superior Financial Programs
- Yes
- Teaching Premium
- $240/28 days
- Wedding leave
- 7 days paid + 7 days without pay
Call
- Call (provincial max)
- 6 calls in an establishment per 28 days
Teaching sites
- CIUSSS de l'Estrie - Hôpital Fleurimont
- CIUSSS de l'Estrie - Hôtel-Dieu
- CHUM - Hôpital Ste-Justine
- Centre de recherche clinique (PET-CT)
Unfilled positions in past years
No repeated vacancies in CaRMS’s lists of open positions, 2019–2026.
Contacts
Contacts weren't collected for the 2026 match.
The current program director and contacts are on the 2027 version of this program and on the CaRMS program page(opens in a new tab).
Location
Sherbrooke, Quebec
About the city
Public statistics for the place named by this program’s location label, each with its source and reference period. They describe the place, not the program, and are not a ranking. Check each source before you rely on it.
Climate
- January average
- −9.5 °C
- July average
- 19.7 °C
- Snowfall
- 290.6 cm a year
- Days below −20 °C
- 23.1 days a year
People
- Population
- 172,950 people
- Official languages
- English only 1.7% · French only 51.6% · English and French 46.1% · neither 0.7%
- Immigrants
- 8.8% of residents
- Indigenous identity
- 1.7% of residents
- How people commute
- car, truck or van 87.3% · public transit 4.9% · walking or cycling 6.4% · other 1.4%
- Median household income
- $62,400 before tax
Rural and remote
- Population centre
- Sherbrooke, a large urban population centre (100,000 or more people)
- Remoteness index
- 0.156
Housing, cost and work
- Rental vacancy rate
- 2.7%
- Basic cost of living
- $47,414 a year
- Unemployment rate
- 4.0%
Job outlook
- Outlook, 2025–2027
- Good
- Canada-wide, to 2033
- Strong risk of Shortage